Internal Medicine Physician– Healthcare Executive Advisory Board Member

About Alzheimer’s Treatment Centers of America (ATCA) Alzheimer’s Treatment Centers of America uses Artificial Intelligence (AI) + Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and brain fog from Long COVID. This is not about research. This is about treating patients. ATCA goes beyond diagnosing Alzheimer’s and dementia to uncover and address root causes through our innovative treatment protocols. Our multidisciplinary team, which includes top business executives and medical professionals with expertise in virtual reality and artificial intelligence, is leading the rollout of ATCA Clinics across the U.S. Why Now? Immediate Revenue: ATCA is expanding to a multi-clinic organisation incorporating a new prime location...We're Launching Our New Clinic in Palm Beach Gardens, Florida. The Alzheimer's Treatment Centers of America ATCA clinic Palm Beach Gardens/Jupiter is located on the first floor of a two storey building with the Cleveland Clinic as a neighboring tenant. It is located in one of the most affluent areas and has replaced a prior urgent care space which has resulted in high levels of uptake with appointments already booked as far as March. In-Network with Insurance: ATCA treatments are covered by Medicare, Medicare Advantage, and most major healthcare insurance providers. Proven Results: In a study using the AI protocol implemented by ATCA, 75% of patients with mild cognitive impairment experienced no further decline. FDA-Approved Treatment: Includes TB006, which is FDA-approved for compassionate use and has the potential to reverse dementias, including Alzheimer’s. Physician-Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. See our Medical Advisory Board:

https://atca.ai/medical-advisory-board/ Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams. Internal Medicine Physician Job Description ATCA is seeking an accomplished Internal Medicine Physician to join its Medical Advisory Board and support the clinical and strategic expansion of a next-generation treatment model for Alzheimer’s disease, dementia, and complex chronic conditions that impact cognitive health. This role is designed for senior internists with broad clinical experience managing patients with multiple comorbidities, longitudinal disease progression, and complex diagnostic profiles. As an Internal Medicine Advisor, you will help ensure ATCA’s precision medicine approach is grounded in comprehensive, whole-patient care while remaining scalable across a growing national clinic network. You will work closely with ATCA’s executive leadership, neurologists, geriatricians, psychiatrists, and data science partners to refine treatment pathways, optimize care coordination, and ensure that systemic contributors to cognitive decline are appropriately identified and addressed. Responsibilities Include Clinical Strategy & Oversight: Provide expert guidance on internal medicine–driven evaluation, diagnosis, and management of patients with Alzheimer’s disease, dementia, and mild cognitive impairment, particularly those with complex chronic conditions. Comorbidity Management: Advise on integrating cardiovascular, metabolic, endocrine, renal, and inflammatory conditions into individualized treatment plans within ATCA’s precision medicine model. Precision Medicine Integration: Guide how laboratory data, imaging, medical history, and longitudinal health metrics should inform AI-assisted treatment decisions. Care Coordination & Continuity: Support the development of coordinated care pathways that align specialty care, primary care, and longitudinal monitoring across ATCA clinics. Quality & Outcomes Review: Review aggregated, de-identified patient outcomes to ensure clinical quality, safety, and continuous improvement across multi-disciplinary care teams. Interdisciplinary Collaboration: Collaborate with physicians, pharmacists, technologists, and executive leadership to align comprehensive medical care with operational scalability and patient experience. Innovation Support: Provide input on emerging internal medicine research, diagnostics, and treatment strategies that may enhance ATCA’s clinical offerings and long-term roadmap. Why Join Us? Transform Patient Outcomes: Help advance a comprehensive model of Alzheimer’s treatment that addresses systemic health drivers of cognitive decline. Influence National Care Delivery: Play a meaningful role in shaping how internal medicine–led cognitive care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where internal medicine expertise directly impacts growth, outcomes, and legacy. Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role. Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.